BIIB - EU regulators issue positive opinion for Biogen Friedreich's Ataxia drug
2023-12-15 12:26:05 ET
More on Biogen
- Biogen: LEQEMBI's $10 Billion Potential
- Biogen Inc. (BIIB) Evercore ISI 6th Annual HealthCONx Conference (Transcript)
- Biogen's Uncertain Strategic Pivots Amidst MS Market Challenges
- Biogen, Eisai to launch new Alzheimer therapy in Japan
- Biogen named a best idea for 2024 at Cowen
For further details see:
EU regulators issue positive opinion for Biogen Friedreich's Ataxia drug